Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
EG.5.1.12NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EG.5.1.12NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.5.1.12NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.5.1.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.5.1.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.5.1.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
EG.5.1.12NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
EG.5.1.12ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-3925.34Japan
JF.1.1.2ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
JF.1.1.2ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
JF.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JF.1.1.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
JF.1.1.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JF.1.1.2ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
JF.1.1.2ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
JF.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JF.1.1.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JF.1.1.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JF.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JF.1.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JF.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JF.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JF.1.1.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JF.1.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JF.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JF.1.1.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JF.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JF.1.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JF.1.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JF.1.1.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JF.1.1.2ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
HK.11ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
HK.11ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
HK.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HK.11ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
HK.11ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
HK.11ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
HK.11ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
HK.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
HK.11SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
HK.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
HK.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
HK.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used